Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 266 | 2024 | 2148 | 22.730 |
Why?
|
Brain | 199 | 2024 | 1699 | 14.900 |
Why?
|
Aging | 120 | 2023 | 1572 | 10.530 |
Why?
|
Cognitive Dysfunction | 83 | 2023 | 1072 | 9.490 |
Why?
|
TDP-43 Proteinopathies | 23 | 2023 | 110 | 8.210 |
Why?
|
Dementia | 56 | 2023 | 580 | 8.050 |
Why?
|
Aged, 80 and over | 277 | 2024 | 4904 | 7.390 |
Why?
|
Cognition Disorders | 77 | 2023 | 1020 | 6.620 |
Why?
|
Cerebrovascular Disorders | 22 | 2023 | 134 | 5.770 |
Why?
|
DNA-Binding Proteins | 37 | 2023 | 275 | 5.650 |
Why?
|
Cognition | 70 | 2024 | 1371 | 5.410 |
Why?
|
Aged | 275 | 2024 | 9339 | 5.410 |
Why?
|
Cerebral Amyloid Angiopathy | 26 | 2023 | 114 | 5.360 |
Why?
|
Amyloid beta-Peptides | 65 | 2024 | 328 | 5.290 |
Why?
|
Humans | 440 | 2024 | 28462 | 5.250 |
Why?
|
Male | 315 | 2024 | 15367 | 5.020 |
Why?
|
Female | 312 | 2024 | 15793 | 4.950 |
Why?
|
Frontotemporal Lobar Degeneration | 12 | 2023 | 30 | 4.400 |
Why?
|
Lewy Body Disease | 20 | 2022 | 99 | 4.090 |
Why?
|
Cohort Studies | 103 | 2024 | 1948 | 3.880 |
Why?
|
Lewy Bodies | 32 | 2023 | 193 | 3.740 |
Why?
|
Cerebral Infarction | 28 | 2020 | 150 | 3.280 |
Why?
|
tau Proteins | 44 | 2023 | 239 | 3.220 |
Why?
|
Genetic Predisposition to Disease | 33 | 2022 | 382 | 3.180 |
Why?
|
Longitudinal Studies | 84 | 2023 | 1391 | 2.980 |
Why?
|
Neurofibrillary Tangles | 40 | 2023 | 196 | 2.790 |
Why?
|
Apolipoproteins E | 28 | 2023 | 254 | 2.750 |
Why?
|
Neuropsychological Tests | 71 | 2022 | 1254 | 2.720 |
Why?
|
Parkinsonian Disorders | 13 | 2023 | 227 | 2.650 |
Why?
|
Autopsy | 56 | 2023 | 346 | 2.600 |
Why?
|
Hippocampus | 21 | 2022 | 281 | 2.550 |
Why?
|
Plaque, Amyloid | 34 | 2023 | 147 | 2.500 |
Why?
|
Nervous System Diseases | 12 | 2023 | 121 | 2.440 |
Why?
|
Arteriolosclerosis | 12 | 2023 | 78 | 2.380 |
Why?
|
Apolipoprotein E4 | 26 | 2023 | 267 | 2.380 |
Why?
|
Neurodegenerative Diseases | 11 | 2023 | 124 | 2.350 |
Why?
|
Nerve Tissue Proteins | 15 | 2022 | 154 | 2.320 |
Why?
|
Cerebral Small Vessel Diseases | 5 | 2023 | 13 | 2.220 |
Why?
|
Brain Infarction | 12 | 2020 | 75 | 2.050 |
Why?
|
Memory | 19 | 2020 | 308 | 2.010 |
Why?
|
Membrane Proteins | 14 | 2022 | 174 | 2.000 |
Why?
|
Parkinson Disease | 17 | 2023 | 847 | 1.980 |
Why?
|
White Matter | 13 | 2023 | 142 | 1.960 |
Why?
|
Independent Living | 19 | 2023 | 320 | 1.950 |
Why?
|
Cerebral Cortex | 11 | 2021 | 164 | 1.900 |
Why?
|
Diet, Mediterranean | 5 | 2023 | 101 | 1.860 |
Why?
|
Hypertension | 5 | 2023 | 226 | 1.740 |
Why?
|
Intracranial Arteriosclerosis | 12 | 2022 | 53 | 1.700 |
Why?
|
Limbic Encephalitis | 3 | 2023 | 12 | 1.690 |
Why?
|
Amyotrophic Lateral Sclerosis | 4 | 2023 | 24 | 1.670 |
Why?
|
Neuropathology | 15 | 2023 | 85 | 1.650 |
Why?
|
Genotype | 31 | 2023 | 352 | 1.640 |
Why?
|
Cognitive Aging | 8 | 2021 | 79 | 1.590 |
Why?
|
Polymorphism, Single Nucleotide | 25 | 2022 | 285 | 1.590 |
Why?
|
Genome-Wide Association Study | 29 | 2022 | 291 | 1.580 |
Why?
|
Memory Disorders | 10 | 2018 | 171 | 1.560 |
Why?
|
Magnetic Resonance Imaging | 32 | 2023 | 1196 | 1.550 |
Why?
|
Genetic Loci | 7 | 2019 | 54 | 1.500 |
Why?
|
Risk Factors | 57 | 2023 | 2421 | 1.450 |
Why?
|
Brain Diseases | 7 | 2021 | 67 | 1.450 |
Why?
|
Microglia | 16 | 2021 | 145 | 1.420 |
Why?
|
Dementia, Vascular | 7 | 2023 | 45 | 1.400 |
Why?
|
Atherosclerosis | 4 | 2023 | 56 | 1.400 |
Why?
|
Biomarkers | 20 | 2023 | 601 | 1.330 |
Why?
|
Sex Characteristics | 7 | 2023 | 120 | 1.280 |
Why?
|
Temporal Lobe | 10 | 2020 | 86 | 1.270 |
Why?
|
Amyloid | 11 | 2021 | 58 | 1.270 |
Why?
|
Frontotemporal Dementia | 3 | 2023 | 13 | 1.230 |
Why?
|
Disease Progression | 24 | 2022 | 719 | 1.230 |
Why?
|
Neurons | 18 | 2022 | 341 | 1.220 |
Why?
|
Motor Disorders | 3 | 2023 | 24 | 1.180 |
Why?
|
Genetic Association Studies | 12 | 2020 | 86 | 1.170 |
Why?
|
Prospective Studies | 34 | 2023 | 1810 | 1.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 7 | 2020 | 67 | 1.160 |
Why?
|
Follow-Up Studies | 35 | 2021 | 1868 | 1.130 |
Why?
|
Brain Injuries, Traumatic | 4 | 2022 | 22 | 1.130 |
Why?
|
Proteomics | 11 | 2023 | 93 | 1.100 |
Why?
|
Tauopathies | 7 | 2023 | 21 | 1.090 |
Why?
|
Transcriptome | 8 | 2022 | 88 | 1.080 |
Why?
|
alpha-Synuclein | 8 | 2020 | 132 | 1.070 |
Why?
|
Geriatric Assessment | 9 | 2017 | 214 | 1.070 |
Why?
|
Hospitalization | 2 | 2019 | 322 | 1.070 |
Why?
|
DNA Methylation | 11 | 2021 | 163 | 0.980 |
Why?
|
Memory, Episodic | 10 | 2023 | 116 | 0.940 |
Why?
|
Cerebrovascular Circulation | 3 | 2022 | 35 | 0.940 |
Why?
|
Spinal Cord | 5 | 2022 | 84 | 0.920 |
Why?
|
Genetic Variation | 9 | 2021 | 100 | 0.880 |
Why?
|
Middle Aged | 54 | 2022 | 9306 | 0.870 |
Why?
|
Cytomegalovirus Infections | 2 | 2013 | 35 | 0.840 |
Why?
|
Sclerosis | 12 | 2022 | 66 | 0.810 |
Why?
|
Age Factors | 20 | 2021 | 793 | 0.800 |
Why?
|
Prefrontal Cortex | 8 | 2021 | 149 | 0.790 |
Why?
|
Cognitive Reserve | 5 | 2022 | 39 | 0.790 |
Why?
|
Blood Pressure | 3 | 2020 | 204 | 0.790 |
Why?
|
Tumor Suppressor Proteins | 5 | 2021 | 35 | 0.780 |
Why?
|
Frontal Lobe | 10 | 2022 | 83 | 0.780 |
Why?
|
United States | 24 | 2021 | 2185 | 0.770 |
Why?
|
Brain Chemistry | 7 | 2021 | 44 | 0.730 |
Why?
|
Substantia Nigra | 5 | 2021 | 123 | 0.720 |
Why?
|
Aniline Compounds | 9 | 2017 | 36 | 0.710 |
Why?
|
Neuroimaging | 10 | 2021 | 133 | 0.700 |
Why?
|
Alleles | 16 | 2023 | 213 | 0.700 |
Why?
|
Educational Status | 10 | 2023 | 298 | 0.690 |
Why?
|
Severity of Illness Index | 18 | 2021 | 992 | 0.670 |
Why?
|
Ethylene Glycols | 7 | 2017 | 11 | 0.670 |
Why?
|
Hearing Loss | 4 | 2017 | 19 | 0.660 |
Why?
|
Cross-Sectional Studies | 15 | 2022 | 939 | 0.650 |
Why?
|
Synapses | 4 | 2021 | 36 | 0.630 |
Why?
|
Neurology | 1 | 2020 | 58 | 0.630 |
Why?
|
Cerebral Arteries | 3 | 2016 | 25 | 0.630 |
Why?
|
Animals | 28 | 2022 | 3798 | 0.630 |
Why?
|
Gene Expression | 8 | 2019 | 203 | 0.620 |
Why?
|
Epigenesis, Genetic | 5 | 2021 | 86 | 0.620 |
Why?
|
Emergencies | 1 | 2019 | 35 | 0.620 |
Why?
|
Models, Neurological | 1 | 2018 | 26 | 0.600 |
Why?
|
Phenotype | 11 | 2021 | 308 | 0.600 |
Why?
|
Linear Models | 13 | 2020 | 255 | 0.590 |
Why?
|
Folic Acid | 4 | 2006 | 21 | 0.590 |
Why?
|
Neural Pathways | 1 | 2018 | 73 | 0.590 |
Why?
|
Stroke | 6 | 2023 | 278 | 0.580 |
Why?
|
Polymorphism, Genetic | 4 | 2017 | 59 | 0.580 |
Why?
|
Dietary Supplements | 3 | 2006 | 67 | 0.570 |
Why?
|
Logistic Models | 13 | 2019 | 397 | 0.560 |
Why?
|
Nuclear Proteins | 5 | 2020 | 86 | 0.560 |
Why?
|
Mutation | 7 | 2022 | 349 | 0.560 |
Why?
|
Receptors, Immunologic | 4 | 2020 | 28 | 0.550 |
Why?
|
Exercise | 6 | 2021 | 476 | 0.540 |
Why?
|
Membrane Glycoproteins | 4 | 2020 | 69 | 0.540 |
Why?
|
Comorbidity | 13 | 2021 | 502 | 0.530 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 373 | 0.530 |
Why?
|
Motor Activity | 5 | 2019 | 331 | 0.530 |
Why?
|
Positron-Emission Tomography | 8 | 2023 | 90 | 0.530 |
Why?
|
Psychiatric Status Rating Scales | 9 | 2016 | 329 | 0.530 |
Why?
|
Patient Selection | 2 | 2021 | 209 | 0.520 |
Why?
|
Olfaction Disorders | 4 | 2021 | 47 | 0.500 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2015 | 10 | 0.500 |
Why?
|
SNARE Proteins | 3 | 2021 | 13 | 0.500 |
Why?
|
Psychomotor Performance | 6 | 2021 | 213 | 0.480 |
Why?
|
Atrophy | 6 | 2021 | 91 | 0.470 |
Why?
|
Infarction | 3 | 2023 | 30 | 0.460 |
Why?
|
Tissue Donors | 2 | 2012 | 79 | 0.460 |
Why?
|
Peptide Fragments | 6 | 2018 | 77 | 0.450 |
Why?
|
Amyloidosis | 4 | 2022 | 27 | 0.440 |
Why?
|
Apolipoprotein E2 | 3 | 2023 | 12 | 0.440 |
Why?
|
Community Health Services | 2 | 2017 | 36 | 0.440 |
Why?
|
Neocortex | 4 | 2019 | 32 | 0.440 |
Why?
|
Social Behavior | 1 | 2013 | 72 | 0.430 |
Why?
|
Hearing Aids | 4 | 2012 | 7 | 0.420 |
Why?
|
Research Design | 5 | 2021 | 208 | 0.420 |
Why?
|
Depression | 7 | 2022 | 454 | 0.410 |
Why?
|
Cerebral Hemorrhage | 4 | 2023 | 108 | 0.410 |
Why?
|
Sequence Analysis, RNA | 7 | 2020 | 43 | 0.410 |
Why?
|
Neuropeptides | 3 | 2023 | 30 | 0.400 |
Why?
|
Genome, Human | 3 | 2018 | 46 | 0.400 |
Why?
|
Life Style | 1 | 2013 | 198 | 0.400 |
Why?
|
Dietary Approaches To Stop Hypertension | 2 | 2023 | 37 | 0.390 |
Why?
|
Adult | 18 | 2023 | 8152 | 0.390 |
Why?
|
Membrane Transport Proteins | 5 | 2022 | 56 | 0.390 |
Why?
|
Antibodies, Antiphospholipid | 3 | 2019 | 25 | 0.380 |
Why?
|
Apoptosis | 1 | 2012 | 203 | 0.380 |
Why?
|
Immunohistochemistry | 10 | 2020 | 364 | 0.370 |
Why?
|
Social Support | 2 | 2010 | 216 | 0.370 |
Why?
|
Diabetes Mellitus | 5 | 2021 | 137 | 0.360 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 3 | 2019 | 26 | 0.360 |
Why?
|
Surveys and Questionnaires | 12 | 2023 | 1216 | 0.360 |
Why?
|
RNA Splicing Factors | 2 | 2020 | 6 | 0.360 |
Why?
|
Residence Characteristics | 7 | 2018 | 216 | 0.350 |
Why?
|
National Institute on Aging (U.S.) | 6 | 2019 | 17 | 0.350 |
Why?
|
Heterozygote | 5 | 2018 | 103 | 0.350 |
Why?
|
Seafood | 2 | 2016 | 14 | 0.350 |
Why?
|
RNA | 5 | 2023 | 38 | 0.340 |
Why?
|
Iron | 2 | 2021 | 21 | 0.340 |
Why?
|
Astrocytes | 4 | 2020 | 151 | 0.340 |
Why?
|
Amygdala | 2 | 2021 | 43 | 0.340 |
Why?
|
Case-Control Studies | 10 | 2019 | 600 | 0.340 |
Why?
|
Vitamin B Complex | 2 | 2006 | 6 | 0.330 |
Why?
|
Chicago | 8 | 2021 | 941 | 0.330 |
Why?
|
Circadian Rhythm | 3 | 2021 | 297 | 0.330 |
Why?
|
Incidence | 14 | 2019 | 779 | 0.320 |
Why?
|
Quality of Life | 4 | 2017 | 660 | 0.320 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 140 | 0.320 |
Why?
|
Vascular Diseases | 3 | 2019 | 44 | 0.320 |
Why?
|
Transcription Factors | 2 | 2021 | 171 | 0.310 |
Why?
|
Odds Ratio | 9 | 2017 | 274 | 0.310 |
Why?
|
Vitamin B 12 | 2 | 2006 | 13 | 0.310 |
Why?
|
Sulfonylurea Receptors | 2 | 2021 | 3 | 0.310 |
Why?
|
Diet | 3 | 2014 | 221 | 0.310 |
Why?
|
Algorithms | 4 | 2020 | 378 | 0.310 |
Why?
|
Haplotypes | 5 | 2020 | 56 | 0.300 |
Why?
|
Sleep Deprivation | 3 | 2019 | 75 | 0.300 |
Why?
|
Medicare | 2 | 2019 | 121 | 0.300 |
Why?
|
Microvessels | 2 | 2019 | 14 | 0.300 |
Why?
|
Postmortem Changes | 6 | 2016 | 32 | 0.300 |
Why?
|
Memory, Short-Term | 3 | 2022 | 103 | 0.300 |
Why?
|
Frail Elderly | 3 | 2014 | 53 | 0.290 |
Why?
|
Housing for the Elderly | 1 | 2007 | 8 | 0.290 |
Why?
|
gamma-Tocopherol | 2 | 2020 | 9 | 0.280 |
Why?
|
Proteins | 2 | 2020 | 66 | 0.280 |
Why?
|
Religious Personnel | 2 | 2018 | 11 | 0.280 |
Why?
|
Awareness | 2 | 2019 | 45 | 0.280 |
Why?
|
Stress, Psychological | 4 | 2012 | 243 | 0.280 |
Why?
|
Inflammation | 3 | 2019 | 288 | 0.280 |
Why?
|
Health Literacy | 2 | 2020 | 109 | 0.280 |
Why?
|
Insulin Resistance | 2 | 2021 | 52 | 0.270 |
Why?
|
Copper | 2 | 2022 | 18 | 0.270 |
Why?
|
Sleep Wake Disorders | 3 | 2019 | 130 | 0.270 |
Why?
|
Movement Disorders | 2 | 2021 | 91 | 0.270 |
Why?
|
Interneurons | 1 | 2006 | 5 | 0.270 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 279 | 0.260 |
Why?
|
Urinary Incontinence | 2 | 2017 | 23 | 0.260 |
Why?
|
Entorhinal Cortex | 1 | 2006 | 36 | 0.260 |
Why?
|
Synucleins | 2 | 2018 | 8 | 0.260 |
Why?
|
Brain Mapping | 5 | 2022 | 168 | 0.260 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2017 | 48 | 0.260 |
Why?
|
Time Factors | 7 | 2021 | 1497 | 0.260 |
Why?
|
Sialic Acid Binding Ig-like Lectin 3 | 3 | 2015 | 14 | 0.260 |
Why?
|
LDL-Receptor Related Proteins | 4 | 2022 | 17 | 0.260 |
Why?
|
Presynaptic Terminals | 3 | 2023 | 11 | 0.260 |
Why?
|
Presbycusis | 3 | 2011 | 8 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2023 | 72 | 0.250 |
Why?
|
Mice | 10 | 2022 | 1467 | 0.250 |
Why?
|
Proteome | 3 | 2023 | 42 | 0.250 |
Why?
|
Food, Fortified | 1 | 2005 | 9 | 0.250 |
Why?
|
Mental Status Schedule | 5 | 2018 | 98 | 0.240 |
Why?
|
Synaptotagmins | 2 | 2021 | 5 | 0.240 |
Why?
|
Models, Statistical | 4 | 2013 | 128 | 0.240 |
Why?
|
Gene Frequency | 4 | 2017 | 60 | 0.240 |
Why?
|
Gray Matter | 3 | 2020 | 55 | 0.240 |
Why?
|
Insulin | 3 | 2021 | 90 | 0.240 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 321 | 0.230 |
Why?
|
Phosphorylation | 7 | 2021 | 149 | 0.230 |
Why?
|
Diagnosis | 4 | 2018 | 24 | 0.230 |
Why?
|
Mice, Transgenic | 7 | 2022 | 227 | 0.230 |
Why?
|
Databases, Factual | 4 | 2020 | 358 | 0.230 |
Why?
|
Fluorine Radioisotopes | 2 | 2014 | 5 | 0.230 |
Why?
|
Antihypertensive Agents | 2 | 2019 | 71 | 0.230 |
Why?
|
Vitamin D | 2 | 2022 | 41 | 0.230 |
Why?
|
Adaptor Proteins, Vesicular Transport | 3 | 2021 | 42 | 0.220 |
Why?
|
Gait Disorders, Neurologic | 1 | 2006 | 137 | 0.220 |
Why?
|
DNA | 2 | 2005 | 104 | 0.220 |
Why?
|
Healthy Lifestyle | 1 | 2024 | 46 | 0.220 |
Why?
|
Microcirculation | 4 | 2018 | 29 | 0.220 |
Why?
|
Multiple Sclerosis | 2 | 2022 | 102 | 0.220 |
Why?
|
Blood-Brain Barrier | 4 | 2019 | 39 | 0.210 |
Why?
|
Rest | 2 | 2021 | 33 | 0.210 |
Why?
|
Resilience, Psychological | 1 | 2023 | 30 | 0.210 |
Why?
|
Sleep | 3 | 2019 | 355 | 0.210 |
Why?
|
Organ Size | 4 | 2019 | 107 | 0.210 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2016 | 22 | 0.210 |
Why?
|
Locus Coeruleus | 2 | 2013 | 20 | 0.210 |
Why?
|
Insulins | 1 | 2022 | 4 | 0.210 |
Why?
|
Lymphatic Vessels | 1 | 2022 | 9 | 0.210 |
Why?
|
Parietal Lobe | 2 | 2021 | 17 | 0.210 |
Why?
|
Societies | 2 | 2020 | 6 | 0.210 |
Why?
|
Flavonols | 1 | 2022 | 11 | 0.210 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2022 | 57 | 0.210 |
Why?
|
Statistics as Topic | 6 | 2017 | 113 | 0.200 |
Why?
|
Exonucleases | 1 | 2022 | 2 | 0.200 |
Why?
|
HSP27 Heat-Shock Proteins | 2 | 2019 | 18 | 0.200 |
Why?
|
Prodromal Symptoms | 2 | 2020 | 19 | 0.200 |
Why?
|
Anxiety | 3 | 2013 | 161 | 0.200 |
Why?
|
Fatty Acids | 3 | 2018 | 41 | 0.200 |
Why?
|
Unconsciousness | 1 | 2022 | 9 | 0.200 |
Why?
|
Diet, Western | 1 | 2022 | 12 | 0.200 |
Why?
|
Bone Marrow | 1 | 2022 | 81 | 0.200 |
Why?
|
Arterioles | 3 | 2020 | 12 | 0.200 |
Why?
|
Actigraphy | 6 | 2021 | 101 | 0.200 |
Why?
|
Epidemiologic Studies | 4 | 2012 | 25 | 0.200 |
Why?
|
ORAI2 Protein | 1 | 2021 | 2 | 0.200 |
Why?
|
RNA Editing | 1 | 2021 | 2 | 0.200 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 236 | 0.200 |
Why?
|
Anthocyanins | 1 | 2022 | 11 | 0.200 |
Why?
|
Fruit | 1 | 2022 | 26 | 0.190 |
Why?
|
WW Domain-Containing Oxidoreductase | 1 | 2021 | 1 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2021 | 1 | 0.190 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 23 | 0.190 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2021 | 1 | 0.190 |
Why?
|
Synapsins | 2 | 2021 | 6 | 0.190 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 199 | 0.190 |
Why?
|
Mental Recall | 2 | 2020 | 71 | 0.190 |
Why?
|
Cerebral Arterial Diseases | 1 | 2021 | 9 | 0.190 |
Why?
|
Perception | 2 | 2019 | 76 | 0.190 |
Why?
|
Netrins | 1 | 2021 | 2 | 0.190 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 61 | 0.190 |
Why?
|
Cause of Death | 1 | 2021 | 65 | 0.190 |
Why?
|
Adaptation, Psychological | 2 | 2020 | 183 | 0.190 |
Why?
|
MicroRNAs | 1 | 2022 | 54 | 0.190 |
Why?
|
Phospholipase D | 1 | 2021 | 5 | 0.190 |
Why?
|
Mental Status and Dementia Tests | 2 | 2019 | 69 | 0.190 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 61 | 0.190 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 23 | 0.190 |
Why?
|
Epistasis, Genetic | 2 | 2020 | 9 | 0.180 |
Why?
|
CA2 Region, Hippocampal | 1 | 2021 | 1 | 0.180 |
Why?
|
Retrospective Studies | 6 | 2022 | 3612 | 0.180 |
Why?
|
Radiopharmaceuticals | 2 | 2012 | 54 | 0.180 |
Why?
|
Vitamin K | 1 | 2021 | 7 | 0.180 |
Why?
|
Biomedical Research | 1 | 2021 | 66 | 0.180 |
Why?
|
Adaptive Immunity | 1 | 2021 | 19 | 0.180 |
Why?
|
Proteostasis Deficiencies | 1 | 2020 | 1 | 0.180 |
Why?
|
Sex Factors | 7 | 2020 | 480 | 0.180 |
Why?
|
Memory and Learning Tests | 1 | 2020 | 7 | 0.180 |
Why?
|
Serial Learning | 1 | 2020 | 7 | 0.180 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 83 | 0.180 |
Why?
|
RNA, Messenger | 3 | 2017 | 303 | 0.180 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2021 | 93 | 0.180 |
Why?
|
Late Onset Disorders | 1 | 2020 | 6 | 0.180 |
Why?
|
B-Lymphocytes | 1 | 2021 | 56 | 0.180 |
Why?
|
Specimen Handling | 1 | 2021 | 44 | 0.180 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 39 | 0.180 |
Why?
|
Mutation, Missense | 1 | 2020 | 26 | 0.180 |
Why?
|
Personality | 2 | 2013 | 56 | 0.180 |
Why?
|
Peptides | 1 | 2021 | 106 | 0.180 |
Why?
|
T-Lymphocytes | 1 | 2021 | 98 | 0.180 |
Why?
|
Organ Specificity | 2 | 2020 | 43 | 0.180 |
Why?
|
Intersectoral Collaboration | 1 | 2020 | 7 | 0.170 |
Why?
|
Neovascularization, Pathologic | 2 | 2011 | 36 | 0.170 |
Why?
|
CpG Islands | 5 | 2021 | 53 | 0.170 |
Why?
|
Mortality | 2 | 2021 | 88 | 0.170 |
Why?
|
Amyloid Neuropathies | 1 | 2020 | 4 | 0.170 |
Why?
|
Regression Analysis | 5 | 2018 | 267 | 0.170 |
Why?
|
Bromine | 1 | 2020 | 2 | 0.170 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2022 | 18 | 0.170 |
Why?
|
Signal Transduction | 5 | 2021 | 448 | 0.170 |
Why?
|
Research | 1 | 2020 | 43 | 0.170 |
Why?
|
Homozygote | 1 | 2020 | 20 | 0.170 |
Why?
|
Tuberous Sclerosis | 2 | 2017 | 15 | 0.170 |
Why?
|
Cell Nucleus | 1 | 2020 | 79 | 0.170 |
Why?
|
Neurites | 3 | 2020 | 9 | 0.170 |
Why?
|
Child Development | 1 | 2020 | 75 | 0.170 |
Why?
|
Sensitivity and Specificity | 5 | 2023 | 520 | 0.170 |
Why?
|
Cell Count | 6 | 2021 | 78 | 0.170 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 2 | 0.170 |
Why?
|
Olfactory Bulb | 1 | 2019 | 17 | 0.170 |
Why?
|
Illinois | 1 | 2020 | 247 | 0.170 |
Why?
|
Neurocognitive Disorders | 1 | 2019 | 13 | 0.160 |
Why?
|
Adenylate Kinase | 1 | 2019 | 6 | 0.160 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 7 | 0.160 |
Why?
|
Cost of Illness | 1 | 2020 | 53 | 0.160 |
Why?
|
Literacy | 1 | 2019 | 15 | 0.160 |
Why?
|
Fraud | 1 | 2019 | 20 | 0.160 |
Why?
|
Immunity | 1 | 2019 | 15 | 0.160 |
Why?
|
Gait | 1 | 2023 | 411 | 0.160 |
Why?
|
Reward | 1 | 2019 | 27 | 0.160 |
Why?
|
Transcription, Genetic | 2 | 2020 | 108 | 0.160 |
Why?
|
Motor Neurons | 1 | 2018 | 18 | 0.160 |
Why?
|
Histones | 1 | 2018 | 28 | 0.160 |
Why?
|
Histocytochemistry | 1 | 2018 | 17 | 0.160 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2018 | 6 | 0.160 |
Why?
|
Lipids | 1 | 2019 | 51 | 0.160 |
Why?
|
E2F Transcription Factors | 1 | 2018 | 5 | 0.150 |
Why?
|
Decision Making | 1 | 2021 | 227 | 0.150 |
Why?
|
Suprachiasmatic Nucleus | 2 | 2015 | 13 | 0.150 |
Why?
|
Claudins | 1 | 2018 | 6 | 0.150 |
Why?
|
Serpins | 1 | 2018 | 4 | 0.150 |
Why?
|
Choice Behavior | 1 | 2019 | 47 | 0.150 |
Why?
|
Seasons | 1 | 2018 | 24 | 0.150 |
Why?
|
Disease Models, Animal | 5 | 2022 | 628 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
Estradiol | 1 | 2018 | 41 | 0.150 |
Why?
|
Muscle Proteins | 1 | 2018 | 32 | 0.150 |
Why?
|
Military Personnel | 1 | 2018 | 40 | 0.150 |
Why?
|
Reproducibility of Results | 5 | 2023 | 726 | 0.150 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2015 | 17 | 0.150 |
Why?
|
Risk | 6 | 2019 | 208 | 0.150 |
Why?
|
Movement | 1 | 2018 | 117 | 0.150 |
Why?
|
GPI-Linked Proteins | 3 | 2023 | 21 | 0.150 |
Why?
|
Leukoencephalopathies | 1 | 2018 | 12 | 0.150 |
Why?
|
Nerve Degeneration | 2 | 2020 | 49 | 0.150 |
Why?
|
Homocysteine | 1 | 2017 | 8 | 0.150 |
Why?
|
Genetic Testing | 3 | 2019 | 58 | 0.150 |
Why?
|
Linkage Disequilibrium | 4 | 2017 | 36 | 0.150 |
Why?
|
Central Nervous System | 1 | 2018 | 58 | 0.140 |
Why?
|
Phospholipase C gamma | 1 | 2017 | 8 | 0.140 |
Why?
|
RNA, Untranslated | 1 | 2017 | 4 | 0.140 |
Why?
|
Diabetes Complications | 4 | 2021 | 59 | 0.140 |
Why?
|
Prevalence | 4 | 2012 | 473 | 0.140 |
Why?
|
Learning | 1 | 2018 | 71 | 0.140 |
Why?
|
Inclusion Bodies | 3 | 2014 | 13 | 0.140 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2017 | 4 | 0.140 |
Why?
|
Microfilament Proteins | 1 | 2017 | 25 | 0.140 |
Why?
|
Drosophila | 2 | 2021 | 8 | 0.140 |
Why?
|
Quantitative Trait Loci | 4 | 2020 | 46 | 0.140 |
Why?
|
Help-Seeking Behavior | 1 | 2017 | 1 | 0.140 |
Why?
|
Vision, Low | 1 | 2017 | 1 | 0.140 |
Why?
|
Veterans | 1 | 2018 | 93 | 0.140 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2017 | 69 | 0.140 |
Why?
|
Immunity, Innate | 1 | 2017 | 58 | 0.140 |
Why?
|
Presenilin-1 | 2 | 2013 | 8 | 0.140 |
Why?
|
Activities of Daily Living | 3 | 2011 | 612 | 0.130 |
Why?
|
PubMed | 1 | 2016 | 10 | 0.130 |
Why?
|
Walking | 3 | 2023 | 263 | 0.130 |
Why?
|
Translational Medical Research | 1 | 2016 | 1 | 0.130 |
Why?
|
Mercury | 1 | 2016 | 10 | 0.130 |
Why?
|
Munc18 Proteins | 1 | 2015 | 3 | 0.130 |
Why?
|
GABAergic Neurons | 1 | 2015 | 4 | 0.130 |
Why?
|
Causality | 3 | 2021 | 56 | 0.130 |
Why?
|
Receptors, Complement 3b | 2 | 2016 | 15 | 0.130 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2015 | 14 | 0.130 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2015 | 3 | 0.120 |
Why?
|
Monomeric Clathrin Assembly Proteins | 1 | 2015 | 6 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2017 | 161 | 0.120 |
Why?
|
Visceral Afferents | 1 | 2015 | 4 | 0.120 |
Why?
|
Spinal Cord Dorsal Horn | 1 | 2015 | 8 | 0.120 |
Why?
|
Health Status | 1 | 2017 | 228 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 113 | 0.120 |
Why?
|
B-Lymphocyte Subsets | 1 | 2015 | 3 | 0.120 |
Why?
|
HIV Infections | 1 | 2020 | 486 | 0.120 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2015 | 13 | 0.120 |
Why?
|
Antiporters | 1 | 2015 | 6 | 0.120 |
Why?
|
HLA-DRB5 Chains | 1 | 2015 | 6 | 0.120 |
Why?
|
Multiple System Atrophy | 1 | 2015 | 38 | 0.120 |
Why?
|
Preoptic Area | 1 | 2014 | 6 | 0.120 |
Why?
|
Dietary Fats | 2 | 2006 | 39 | 0.120 |
Why?
|
Ankyrins | 1 | 2014 | 4 | 0.120 |
Why?
|
Congresses as Topic | 3 | 2021 | 31 | 0.120 |
Why?
|
Smoking | 3 | 2020 | 179 | 0.120 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 17 | 0.110 |
Why?
|
alpha-Tocopherol | 1 | 2014 | 13 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2014 | 103 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2021 | 276 | 0.110 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2013 | 3 | 0.110 |
Why?
|
Neoplasms | 1 | 2017 | 242 | 0.110 |
Why?
|
Brain Edema | 1 | 2013 | 19 | 0.110 |
Why?
|
Neurotic Disorders | 2 | 2011 | 19 | 0.110 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2013 | 17 | 0.110 |
Why?
|
Hormone Replacement Therapy | 1 | 2013 | 36 | 0.110 |
Why?
|
Encephalocele | 1 | 2013 | 25 | 0.110 |
Why?
|
Religion | 1 | 2013 | 42 | 0.110 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 352 | 0.110 |
Why?
|
Ubiquitin | 3 | 2008 | 31 | 0.110 |
Why?
|
Language | 1 | 2013 | 69 | 0.110 |
Why?
|
Longevity | 1 | 2013 | 30 | 0.110 |
Why?
|
Influenza, Human | 1 | 2013 | 44 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2012 | 58 | 0.110 |
Why?
|
Fibroblasts | 1 | 2013 | 59 | 0.110 |
Why?
|
Brain Stem | 1 | 2013 | 19 | 0.110 |
Why?
|
Child | 5 | 2020 | 1423 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 41 | 0.110 |
Why?
|
Blindness | 1 | 2013 | 13 | 0.110 |
Why?
|
Psychomotor Disorders | 1 | 2013 | 11 | 0.110 |
Why?
|
Deafness | 1 | 2013 | 14 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2013 | 54 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2009 | 494 | 0.100 |
Why?
|
Menopause | 1 | 2013 | 99 | 0.100 |
Why?
|
PrPC Proteins | 1 | 2012 | 2 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 2012 | 3 | 0.100 |
Why?
|
Monocytes | 1 | 2013 | 63 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2013 | 82 | 0.100 |
Why?
|
Protein Interaction Maps | 3 | 2018 | 15 | 0.100 |
Why?
|
Amyloid Precursor Protein Secretases | 3 | 2019 | 11 | 0.100 |
Why?
|
Epidemiologic Research Design | 1 | 2012 | 16 | 0.100 |
Why?
|
Glucosylceramidase | 1 | 2012 | 17 | 0.100 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 438 | 0.100 |
Why?
|
Child Abuse | 1 | 2012 | 35 | 0.100 |
Why?
|
Rats | 3 | 2021 | 678 | 0.100 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 15 | 0.100 |
Why?
|
Disability Evaluation | 2 | 2011 | 293 | 0.100 |
Why?
|
Mental Disorders | 2 | 2011 | 181 | 0.100 |
Why?
|
Single-Blind Method | 3 | 2020 | 111 | 0.100 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2011 | 5 | 0.100 |
Why?
|
Persons With Hearing Impairments | 1 | 2011 | 5 | 0.100 |
Why?
|
Health Surveys | 4 | 2013 | 92 | 0.100 |
Why?
|
Emotions | 1 | 2012 | 87 | 0.100 |
Why?
|
Mitochondrial Proteins | 2 | 2021 | 42 | 0.100 |
Why?
|
Protein Isoforms | 3 | 2020 | 49 | 0.100 |
Why?
|
Apolipoprotein E3 | 2 | 2023 | 16 | 0.100 |
Why?
|
Age of Onset | 4 | 2014 | 99 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 59 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 235 | 0.090 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2011 | 28 | 0.090 |
Why?
|
Cerebral Angiography | 1 | 2011 | 35 | 0.090 |
Why?
|
Receptor, EphA1 | 1 | 2011 | 3 | 0.090 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 6 | 0.090 |
Why?
|
Peptidylprolyl Isomerase | 2 | 2010 | 6 | 0.090 |
Why?
|
Hemoglobins | 1 | 2012 | 78 | 0.090 |
Why?
|
Hearing Loss, Bilateral | 1 | 2011 | 4 | 0.090 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 19 | 0.090 |
Why?
|
Genome | 1 | 2011 | 9 | 0.090 |
Why?
|
Odorants | 2 | 2009 | 21 | 0.090 |
Why?
|
Neuroglia | 2 | 2015 | 49 | 0.090 |
Why?
|
Antigens, CD | 1 | 2011 | 53 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2014 | 124 | 0.090 |
Why?
|
Cerebral Ventricles | 1 | 2011 | 19 | 0.090 |
Why?
|
Maze Learning | 3 | 2016 | 16 | 0.090 |
Why?
|
Audiometry, Pure-Tone | 4 | 2012 | 17 | 0.090 |
Why?
|
Vitamin E | 1 | 2011 | 45 | 0.090 |
Why?
|
Lysosomes | 2 | 2021 | 26 | 0.090 |
Why?
|
Societies, Medical | 1 | 2012 | 152 | 0.090 |
Why?
|
Motor Skills | 2 | 2021 | 52 | 0.090 |
Why?
|
CA3 Region, Hippocampal | 1 | 2010 | 5 | 0.090 |
Why?
|
Catholicism | 1 | 2010 | 21 | 0.090 |
Why?
|
Vesicular Glutamate Transport Protein 1 | 2 | 2023 | 5 | 0.090 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 20 | 0.090 |
Why?
|
Religion and Psychology | 1 | 2010 | 25 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 3 | 0.090 |
Why?
|
Atlases as Topic | 2 | 2021 | 8 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2010 | 59 | 0.090 |
Why?
|
Neurologic Examination | 3 | 2020 | 115 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 99 | 0.090 |
Why?
|
Australia | 3 | 2017 | 43 | 0.080 |
Why?
|
Refractive Errors | 1 | 2009 | 1 | 0.080 |
Why?
|
Visually Impaired Persons | 1 | 2009 | 1 | 0.080 |
Why?
|
Probability | 3 | 2020 | 91 | 0.080 |
Why?
|
Eyeglasses | 1 | 2009 | 4 | 0.080 |
Why?
|
Health Services | 1 | 2009 | 9 | 0.080 |
Why?
|
Chronic Disease | 3 | 2007 | 442 | 0.080 |
Why?
|
Vision Disorders | 1 | 2009 | 22 | 0.080 |
Why?
|
Molecular Biology | 1 | 2009 | 11 | 0.080 |
Why?
|
Formaldehyde | 1 | 2009 | 9 | 0.080 |
Why?
|
Myelin Sheath | 2 | 2020 | 27 | 0.080 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2009 | 14 | 0.080 |
Why?
|
Axons | 2 | 2020 | 28 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 2100 | 0.080 |
Why?
|
Depressive Disorder | 1 | 2010 | 184 | 0.080 |
Why?
|
Anxiety Disorders | 1 | 2010 | 171 | 0.080 |
Why?
|
Nerve Net | 2 | 2019 | 46 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 2019 | 38 | 0.080 |
Why?
|
Blotting, Western | 3 | 2017 | 148 | 0.080 |
Why?
|
Cell Line | 2 | 2019 | 279 | 0.080 |
Why?
|
Carbon-Nitrogen Lyases | 1 | 2008 | 3 | 0.070 |
Why?
|
Estrogen Receptor beta | 1 | 2008 | 5 | 0.070 |
Why?
|
Health Personnel | 1 | 2009 | 108 | 0.070 |
Why?
|
Multifactorial Inheritance | 2 | 2018 | 25 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2020 | 6 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 15 | 0.070 |
Why?
|
Data Collection | 2 | 2005 | 98 | 0.070 |
Why?
|
Prognosis | 3 | 2018 | 824 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 2 | 2021 | 339 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 54 | 0.070 |
Why?
|
Risk Assessment | 4 | 2015 | 676 | 0.070 |
Why?
|
Agnosia | 1 | 2007 | 9 | 0.070 |
Why?
|
Pilot Projects | 2 | 2021 | 440 | 0.070 |
Why?
|
Hand Strength | 2 | 2023 | 61 | 0.070 |
Why?
|
Long-Term Care | 1 | 2007 | 58 | 0.070 |
Why?
|
Infant | 2 | 2023 | 591 | 0.070 |
Why?
|
Reactive Oxygen Species | 2 | 2018 | 120 | 0.070 |
Why?
|
Vitamin B 6 | 1 | 2006 | 4 | 0.070 |
Why?
|
Trans Fatty Acids | 1 | 2006 | 4 | 0.070 |
Why?
|
NADPH Dehydrogenase | 1 | 2006 | 6 | 0.070 |
Why?
|
Receptors, GABA | 1 | 2006 | 4 | 0.070 |
Why?
|
Diet Surveys | 2 | 2022 | 26 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 317 | 0.070 |
Why?
|
Cell Death | 1 | 2006 | 46 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2006 | 52 | 0.070 |
Why?
|
New South Wales | 3 | 2011 | 6 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2006 | 45 | 0.070 |
Why?
|
Loneliness | 1 | 2007 | 63 | 0.060 |
Why?
|
Urban Health | 1 | 2006 | 23 | 0.060 |
Why?
|
Likelihood Functions | 2 | 2017 | 27 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 47 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 2 | 2018 | 39 | 0.060 |
Why?
|
Adolescent | 3 | 2021 | 2324 | 0.060 |
Why?
|
Heme Oxygenase-1 | 1 | 2005 | 7 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 34 | 0.060 |
Why?
|
Endophenotypes | 2 | 2015 | 11 | 0.060 |
Why?
|
Recombinant Proteins | 2 | 2017 | 211 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 349 | 0.060 |
Why?
|
Immunoprecipitation | 2 | 2014 | 24 | 0.050 |
Why?
|
Eicosapentaenoic Acid | 1 | 2003 | 10 | 0.050 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 12 | 0.050 |
Why?
|
Docosahexaenoic Acids | 1 | 2003 | 12 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 371 | 0.050 |
Why?
|
Psychological Tests | 2 | 2014 | 53 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2018 | 73 | 0.050 |
Why?
|
Nutrition Assessment | 1 | 2003 | 45 | 0.050 |
Why?
|
RNA, Small Nuclear | 1 | 2023 | 2 | 0.050 |
Why?
|
Workflow | 1 | 2023 | 10 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2023 | 14 | 0.050 |
Why?
|
Vesicular Glutamate Transport Proteins | 1 | 2023 | 2 | 0.050 |
Why?
|
Vesicular Glutamate Transport Protein 2 | 1 | 2023 | 2 | 0.050 |
Why?
|
Genetics, Population | 1 | 2003 | 2 | 0.050 |
Why?
|
Lymphatic System | 1 | 2022 | 4 | 0.050 |
Why?
|
Pan troglodytes | 1 | 2003 | 8 | 0.050 |
Why?
|
Evolution, Molecular | 1 | 2003 | 7 | 0.050 |
Why?
|
Arachnoid | 1 | 2022 | 10 | 0.050 |
Why?
|
Radionuclide Imaging | 2 | 2013 | 43 | 0.050 |
Why?
|
Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
Vitamins | 1 | 2022 | 21 | 0.050 |
Why?
|
Nerve Growth Factors | 1 | 2023 | 37 | 0.050 |
Why?
|
Models, Genetic | 1 | 2003 | 35 | 0.050 |
Why?
|
Executive Function | 1 | 2023 | 115 | 0.050 |
Why?
|
Gene Dosage | 2 | 2012 | 18 | 0.050 |
Why?
|
Dura Mater | 1 | 2022 | 16 | 0.050 |
Why?
|
Triglycerides | 1 | 2022 | 62 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2023 | 61 | 0.050 |
Why?
|
Cholesterol | 1 | 2022 | 63 | 0.050 |
Why?
|
Zebrafish | 1 | 2022 | 16 | 0.050 |
Why?
|
Eating | 1 | 2022 | 58 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 56 | 0.050 |
Why?
|
Fatal Outcome | 2 | 2013 | 58 | 0.050 |
Why?
|
Stem Cells | 1 | 2022 | 41 | 0.050 |
Why?
|
Thiazoles | 2 | 2013 | 19 | 0.050 |
Why?
|
Self Stimulation | 1 | 2002 | 8 | 0.050 |
Why?
|
Machine Learning | 1 | 2023 | 71 | 0.050 |
Why?
|
Parahippocampal Gyrus | 1 | 2002 | 6 | 0.050 |
Why?
|
Food | 1 | 2022 | 35 | 0.050 |
Why?
|
Silver Staining | 1 | 2002 | 4 | 0.050 |
Why?
|
Neuropil Threads | 1 | 2002 | 7 | 0.050 |
Why?
|
Individuality | 1 | 2022 | 25 | 0.050 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 8 | 0.050 |
Why?
|
Intermediate Filaments | 1 | 2022 | 20 | 0.050 |
Why?
|
Interdisciplinary Research | 1 | 2021 | 1 | 0.050 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2021 | 2 | 0.050 |
Why?
|
Phosphofructokinase-1, Type C | 1 | 2021 | 2 | 0.050 |
Why?
|
Synaptophysin | 1 | 2021 | 9 | 0.050 |
Why?
|
Qa-SNARE Proteins | 1 | 2021 | 7 | 0.050 |
Why?
|
Caffeine | 1 | 2022 | 58 | 0.050 |
Why?
|
Urban Population | 1 | 2003 | 159 | 0.050 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 20 | 0.050 |
Why?
|
Brazil | 1 | 2021 | 37 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 30 | 0.050 |
Why?
|
Lumbar Vertebrae | 2 | 2018 | 412 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2014 | 4 | 0.050 |
Why?
|
Off-Label Use | 1 | 2021 | 6 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 22 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2021 | 66 | 0.050 |
Why?
|
Visual Acuity | 2 | 2013 | 41 | 0.050 |
Why?
|
Epigenomics | 1 | 2021 | 18 | 0.050 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 23 | 0.050 |
Why?
|
Serotonin | 1 | 2021 | 24 | 0.050 |
Why?
|
Glycolysis | 1 | 2021 | 10 | 0.050 |
Why?
|
HeLa Cells | 1 | 2021 | 42 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2021 | 38 | 0.050 |
Why?
|
beta-Lactamases | 1 | 2021 | 84 | 0.050 |
Why?
|
Child, Preschool | 2 | 2013 | 692 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2020 | 10 | 0.050 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2020 | 5 | 0.050 |
Why?
|
Actinin | 1 | 2020 | 7 | 0.050 |
Why?
|
Vesicular Transport Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
Healthy Volunteers | 1 | 2021 | 44 | 0.050 |
Why?
|
Epoxide Hydrolases | 1 | 2020 | 11 | 0.040 |
Why?
|
Molecular Chaperones | 1 | 2020 | 13 | 0.040 |
Why?
|
Information Dissemination | 1 | 2021 | 21 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 5 | 0.040 |
Why?
|
Species Specificity | 1 | 2020 | 41 | 0.040 |
Why?
|
Computational Biology | 1 | 2020 | 21 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2020 | 68 | 0.040 |
Why?
|
Age Distribution | 2 | 2011 | 90 | 0.040 |
Why?
|
Integrin alphaVbeta3 | 2 | 2011 | 16 | 0.040 |
Why?
|
Body Mass Index | 1 | 2023 | 466 | 0.040 |
Why?
|
Neuropilin-1 | 1 | 2019 | 3 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2019 | 24 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2013 | 97 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2019 | 23 | 0.040 |
Why?
|
Oligodendroglia | 1 | 2020 | 37 | 0.040 |
Why?
|
COS Cells | 1 | 2019 | 40 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2011 | 334 | 0.040 |
Why?
|
Down-Regulation | 2 | 2012 | 101 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 2019 | 38 | 0.040 |
Why?
|
Neprilysin | 1 | 2019 | 11 | 0.040 |
Why?
|
Protein Binding | 1 | 2019 | 132 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2019 | 5 | 0.040 |
Why?
|
Acetylation | 1 | 2018 | 14 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2012 | 42 | 0.040 |
Why?
|
Submandibular Gland | 1 | 2018 | 2 | 0.040 |
Why?
|
Primary Prevention | 1 | 2019 | 34 | 0.040 |
Why?
|
Sampling Studies | 1 | 2018 | 31 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 12 | 0.040 |
Why?
|
Nerve Fibers | 1 | 2018 | 13 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 6 | 0.040 |
Why?
|
DNA Repair | 1 | 2018 | 7 | 0.040 |
Why?
|
Metabolomics | 1 | 2018 | 17 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2018 | 22 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 16 | 0.040 |
Why?
|
Reproduction | 1 | 2018 | 10 | 0.040 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 10 | 0.040 |
Why?
|
Metabolome | 1 | 2018 | 16 | 0.040 |
Why?
|
Phosphoproteins | 1 | 2018 | 28 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2018 | 66 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2019 | 107 | 0.040 |
Why?
|
Neural Stem Cells | 1 | 2018 | 13 | 0.040 |
Why?
|
Fractals | 1 | 2018 | 21 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 146 | 0.040 |
Why?
|
Community Health Planning | 1 | 2018 | 22 | 0.040 |
Why?
|
Gene Library | 1 | 2018 | 7 | 0.040 |
Why?
|
Pericytes | 1 | 2018 | 7 | 0.040 |
Why?
|
Blood Vessels | 1 | 2018 | 14 | 0.040 |
Why?
|
HIV-1 | 1 | 2020 | 235 | 0.040 |
Why?
|
Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
Schizophrenia | 1 | 2018 | 68 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 96 | 0.040 |
Why?
|
Biopsy | 1 | 2018 | 221 | 0.040 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2017 | 1 | 0.040 |
Why?
|
Skin | 1 | 2018 | 116 | 0.040 |
Why?
|
Exome | 1 | 2017 | 7 | 0.040 |
Why?
|
Amyloidogenic Proteins | 1 | 2017 | 3 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2017 | 35 | 0.040 |
Why?
|
Protein Structure, Quaternary | 1 | 2017 | 5 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 10 | 0.040 |
Why?
|
Solubility | 1 | 2017 | 26 | 0.040 |
Why?
|
Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2017 | 12 | 0.040 |
Why?
|
Personality Inventory | 2 | 2007 | 76 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 152 | 0.040 |
Why?
|
Colon | 1 | 2018 | 145 | 0.040 |
Why?
|
Immunotherapy | 1 | 2017 | 57 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 41 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 58 | 0.030 |
Why?
|
Anisotropy | 1 | 2017 | 53 | 0.030 |
Why?
|
Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2016 | 3 | 0.030 |
Why?
|
Hearing Tests | 1 | 2017 | 11 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2016 | 11 | 0.030 |
Why?
|
Consciousness Disorders | 1 | 2016 | 7 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 2016 | 4 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2016 | 17 | 0.030 |
Why?
|
Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2016 | 5 | 0.030 |
Why?
|
Zinc Fingers | 1 | 2016 | 12 | 0.030 |
Why?
|
Chromatin | 1 | 2016 | 17 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 53 | 0.030 |
Why?
|
ROC Curve | 1 | 2016 | 145 | 0.030 |
Why?
|
Selenium | 1 | 2016 | 9 | 0.030 |
Why?
|
Diet Records | 1 | 2016 | 11 | 0.030 |
Why?
|
Arterial Pressure | 1 | 2016 | 13 | 0.030 |
Why?
|
Cerebellum | 1 | 2016 | 43 | 0.030 |
Why?
|
Voluntary Health Agencies | 1 | 2015 | 1 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 188 | 0.030 |
Why?
|
Transcytosis | 1 | 2015 | 1 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2015 | 6 | 0.030 |
Why?
|
Capillaries | 1 | 2015 | 11 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2017 | 154 | 0.030 |
Why?
|
Markov Chains | 1 | 2015 | 32 | 0.030 |
Why?
|
Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2015 | 2 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 49 | 0.030 |
Why?
|
Sacrum | 1 | 2015 | 24 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 10 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 263 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2015 | 13 | 0.030 |
Why?
|
Mass Screening | 1 | 2017 | 185 | 0.030 |
Why?
|
Protective Factors | 1 | 2015 | 27 | 0.030 |
Why?
|
National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2014 | 2 | 0.030 |
Why?
|
Pedigree | 1 | 2015 | 56 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2014 | 4 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2015 | 20 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2014 | 3 | 0.030 |
Why?
|
Homeostasis | 1 | 2015 | 69 | 0.030 |
Why?
|
Introns | 1 | 2014 | 17 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 106 | 0.030 |
Why?
|
beta 2-Glycoprotein I | 1 | 2014 | 7 | 0.030 |
Why?
|
Phosphatidylserines | 1 | 2014 | 7 | 0.030 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2014 | 7 | 0.030 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2014 | 2 | 0.030 |
Why?
|
Galanin | 1 | 2014 | 4 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2014 | 32 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2014 | 29 | 0.030 |
Why?
|
Autoantigens | 1 | 2014 | 25 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2014 | 3619 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2014 | 3 | 0.030 |
Why?
|
Databases as Topic | 1 | 2014 | 15 | 0.030 |
Why?
|
C9orf72 Protein | 1 | 2014 | 1 | 0.030 |
Why?
|
DNA Repeat Expansion | 1 | 2014 | 7 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2015 | 93 | 0.030 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2013 | 5 | 0.030 |
Why?
|
Circle of Willis | 1 | 2013 | 4 | 0.030 |
Why?
|
Clergy | 2 | 2005 | 93 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2014 | 93 | 0.030 |
Why?
|
Autoimmunity | 1 | 2013 | 13 | 0.030 |
Why?
|
HLA-D Antigens | 1 | 2013 | 2 | 0.030 |
Why?
|
Dextrans | 1 | 2013 | 4 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2013 | 18 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 2012 | 9 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 27 | 0.030 |
Why?
|
Image Enhancement | 1 | 2013 | 48 | 0.030 |
Why?
|
Mutation Rate | 1 | 2012 | 4 | 0.030 |
Why?
|
Gene Deletion | 1 | 2012 | 41 | 0.030 |
Why?
|
In Vitro Techniques | 1 | 2013 | 169 | 0.030 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2012 | 4 | 0.030 |
Why?
|
Survival Analysis | 1 | 2013 | 267 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2012 | 12 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2012 | 11 | 0.030 |
Why?
|
Phosphoserine | 1 | 2012 | 5 | 0.030 |
Why?
|
Cerebellar Cortex | 1 | 2012 | 7 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 25 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 47 | 0.020 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2012 | 1 | 0.020 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2012 | 2 | 0.020 |
Why?
|
Autoradiography | 1 | 2012 | 6 | 0.020 |
Why?
|
Cerebrovascular Trauma | 1 | 2011 | 1 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2012 | 28 | 0.020 |
Why?
|
Correction of Hearing Impairment | 1 | 2011 | 4 | 0.020 |
Why?
|
Glucose | 1 | 2012 | 56 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 177 | 0.020 |
Why?
|
Auditory Threshold | 1 | 2011 | 25 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 81 | 0.020 |
Why?
|
Acoustic Stimulation | 1 | 2011 | 57 | 0.020 |
Why?
|
Prenatal Care | 1 | 2011 | 9 | 0.020 |
Why?
|
American Heart Association | 1 | 2011 | 18 | 0.020 |
Why?
|
Cadaver | 1 | 2013 | 389 | 0.020 |
Why?
|
Multigene Family | 1 | 2011 | 9 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2011 | 9 | 0.020 |
Why?
|
Visual Perception | 1 | 2011 | 35 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2011 | 63 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2012 | 536 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 3 | 0.020 |
Why?
|
Nutritional Status | 1 | 2011 | 60 | 0.020 |
Why?
|
Parents | 1 | 2012 | 126 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2011 | 36 | 0.020 |
Why?
|
Phenanthrolines | 1 | 2010 | 4 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 2010 | 6 | 0.020 |
Why?
|
Self Report | 1 | 2012 | 226 | 0.020 |
Why?
|
Social Environment | 1 | 2011 | 84 | 0.020 |
Why?
|
Neurofibrils | 1 | 2010 | 2 | 0.020 |
Why?
|
Dendritic Spines | 1 | 2010 | 9 | 0.020 |
Why?
|
Dendrites | 1 | 2010 | 10 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 311 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 340 | 0.020 |
Why?
|
Optometry | 1 | 2009 | 1 | 0.020 |
Why?
|
Ophthalmology | 1 | 2009 | 4 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 772 | 0.020 |
Why?
|
Gliosis | 1 | 2009 | 6 | 0.020 |
Why?
|
Fixatives | 1 | 2009 | 6 | 0.020 |
Why?
|
Encephalitis | 1 | 2009 | 11 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2009 | 21 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2008 | 34 | 0.020 |
Why?
|
Transglutaminases | 1 | 2008 | 5 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2008 | 13 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2008 | 19 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 22 | 0.020 |
Why?
|
Fatigue | 1 | 2008 | 65 | 0.020 |
Why?
|
Motor Neuron Disease | 1 | 2007 | 4 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2007 | 6 | 0.020 |
Why?
|
Reference Values | 1 | 2008 | 199 | 0.020 |
Why?
|
NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2007 | 3 | 0.020 |
Why?
|
Microtubules | 1 | 2007 | 28 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2007 | 28 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 137 | 0.020 |
Why?
|
Social Isolation | 1 | 2007 | 30 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2006 | 40 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2006 | 104 | 0.020 |
Why?
|
Education | 1 | 2005 | 46 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 2006 | 122 | 0.020 |
Why?
|